News

Hebei Shengxue Dacheng Tangshan Pharmaceutical Co., Ltd. Profile

Hebei Shengxue Dacheng Tangshan Pharmaceutical Co., Ltd. (hereinafter referred to as "Tangshan Company") is located in Fengrun District Industrial Zone, Tangshan City, Hebei Province. Founded in August 2006 and covering an area of 110,000 square meters, it is a state-owned high-tech enterprise mainly engaged in the production and sales of pharmaceutical API & preparations as well as feed additives. As a wholly-owned subsidiary of Hebei Shengxue Dacheng Pharmaceutical Co., Ltd., Tangshan Company is a modern pharmaceutical enterprise jointly held by China Uranium Industry Co., Ltd. and Zhejiang Hanye Co., Ltd. The company’s leading products include Colistin Sulfate, Neomycin Sulfate, Spectinomycin Hydrochloride, Colistin Sulfate Premix, Oxytetracycline Calcium Premix, Chlortetracycline Premix and other products. It ranks among the major manufacturers of Colistin Sulfate at home and abroad. Adhering to superior product quality, the company has obtained multiple authoritative certifications, including the ISO9001:2008 Quality Management System Certificate, China Veterinary GMP Certificate, EU CEP Certificate and EU GMP Certificate. Its products are sold nationwide and exported to dozens of countries and regions across Europe, Southeast Asia, America, Africa and beyond, winning wide recognition from global customers. To adapt to evolving market demands, Tangshan Company continuously increases investment in technological innovation, optimizes product quality and develops new products. Meanwhile, it strictly implements environmental management by adhering to the principle of cleaner production and source pollution control, striving to achieve balanced development of economic and environmental benefits. Guided by the mission of Innovating microbial technology, improving people’s quality of life, and safeguarding human health, and upholding the core values of Responsibility, Safety, Innovation and Collaboration, the company keeps enhancing comprehensive competitiveness. It is committed to building a well-known domestic and international enterprise featured with modern microbial technology and specialized chemical pharmaceuticals.